Proximal Splenic Artery Embolization for Refractory Ascites and Hydrothorax Post-Liver Transplant
- PMID: 36797427
- DOI: 10.1007/s00270-023-03376-3
Proximal Splenic Artery Embolization for Refractory Ascites and Hydrothorax Post-Liver Transplant
Abstract
Purpose: Proximal splenic artery embolization (pSAE) has been advocated as a valuable tool to ameliorate portal hyper-perfusion (PHP). The purpose of this study was to determine the safety and efficacy of pSAE to treat refractory ascites (RA) and/or refractory hydrothorax (RH) in the setting of PHP post-liver transplant.
Material and methods: A total of 30 patients who underwent pSAE for RA and/or RH after liver transplantation (LT) between January 2007 and December 2017 were analyzed retrospectively. The patients were divided into groups according to the time frame from pSAE to clinical resolution in order to identify predictors of RA/RH response to the procedure.
Results: Twenty-four (80%) patients responded to pSAE within three months, whereas 6 (20%) still required additional treatments for RA/RH at three months post-pSAE. In all cases clinical symptoms resolved within six months. Complications after pSAE were as follows: 2 cases of splenic infarction (6.6%), one case of post-splenic embolization syndrome (3.3%), one case of hepatic artery thrombosis (3.3%) and one case of portal vein (PV) thrombosis (3.3%). Increased intraoperative PV flow volume and increased pre-pSAE PV velocity, as well as higher estimated glomerular filtration rate were associated with early RA/RH resolution.
Conclusion: pSAE is safe and effective in treating RA and RH due to PHP after LT. This study suggests that clinical parameters indicating more severe PHP and better kidney function are possible predictors for early response to pSAE.
Keywords: Hepatic artery flow; Kidney function; Portal hyper-perfusion; Portal vein flow; Refractory hepatic hydrothorax.
© 2023. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Similar articles
-
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites After Liver Transplantation: Management With Proximal Splenic Artery Embolization.Transplant Proc. 2016 Mar;48(2):377-9. doi: 10.1016/j.transproceed.2016.01.013. Transplant Proc. 2016. PMID: 27109959
-
Preoperative proximal splenic artery embolization: a safe and efficacious portal decompression technique that improves the outcome of live donor liver transplantation.Transpl Int. 2007 Nov;20(11):947-55. doi: 10.1111/j.1432-2277.2007.00513.x. Epub 2007 Jul 6. Transpl Int. 2007. PMID: 17617180
-
Partial splenic artery embolization for thrombocytopenia and uncontrolled massive ascites after liver transplantation.Transplant Proc. 2012 Apr;44(3):755-6. doi: 10.1016/j.transproceed.2012.01.066. Transplant Proc. 2012. PMID: 22483487
-
Management of ascites and hepatic hydrothorax.Best Pract Res Clin Gastroenterol. 2007;21(1):55-75. doi: 10.1016/j.bpg.2006.07.012. Best Pract Res Clin Gastroenterol. 2007. PMID: 17223497 Review.
-
Splenic Artery Embolization for Splenic Artery Steal Syndrome After Living Donor Liver Transplantation: A Case Report.Transplant Proc. 2022 Dec;54(10):2772-2778. doi: 10.1016/j.transproceed.2022.09.020. Epub 2022 Nov 12. Transplant Proc. 2022. PMID: 36376105 Review.
Cited by
-
Proximal splenic artery embolization for treatment of refractory ascites, a single-center experience.Hepatol Res. 2024 Sep 28:10.1111/hepr.14116. doi: 10.1111/hepr.14116. Online ahead of print. Hepatol Res. 2024. PMID: 39340746
-
Living Donor Liver Transplantation with Small Left Lobe Grafts: Prospective Validation of Utility of Splenectomy in Selected Recipients.Ann Transplant. 2025 Jan 14;30:e946374. doi: 10.12659/AOT.946374. Ann Transplant. 2025. PMID: 39806794 Free PMC article.
References
-
- Siqueira F, Kelly T, Saab S. Refractory ascites: pathogenesis, clinical impact, and management. Gastroenterol Hepatol. 2009;5(9):647–56.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical